Drug recall D-1099-2018
Product
Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.
Reason for recall
Defective Container: Customer complaints of punctures in the bottle.
Lots and codes
Lot #: ZCXM, Exp 01NOV2020; ZCXN, Exp 02NOV2020; ZCXP, Exp 09NOV2020; ZCXS, 10NOV2020; ZCXT, Exp 13NOV2020; and ZCXV, Exp 17NOV2020
Recall details
- Recalling firm
- Orexigen Therapeutics, Inc., La Jolla, CA
- Quantity
- 95,296 bottles
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 9, 2018
- Terminated
- November 15, 2019
Related products
- Contrave – drug information
- NDC 51267-890 Contrave Extended-Release · Naltrexone Hydrochloride 8 mg/1; Bupropion Hydrochloride 90… · Nalpropion Pharmaceuticals LLC